{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:43:23Z","timestamp":1789469003380,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xops.2026.101321","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:24:00Z","timestamp":1783700640000},"page":"101321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hard Exudates in Diabetic Macular Edema: Automated OCT Quantification and Longitudinal Response to Faricimab"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1663-6461","authenticated-orcid":false,"given":"Giovanni","family":"Scalabrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Perego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2969-8610","authenticated-orcid":false,"given":"Matteo","family":"Capobianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0148-5348","authenticated-orcid":false,"given":"Daniele","family":"Veritti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0323-967X","authenticated-orcid":false,"given":"Pasquale","family":"Viggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Boscia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3238-9682","authenticated-orcid":false,"given":"Francesco","family":"Bandello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosangela","family":"Lattanzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2938-0409","authenticated-orcid":false,"given":"Maria Vittoria","family":"Cicinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.xops.2026.101321_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S2213-8587(16)30052-3","article-title":"Diabetic macular oedema","volume":"5","author":"Tan","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.xops.2026.101321_bib2","article-title":"The role of inflammation and neurodegeneration in diabetic macular edema. Review","volume":"13","author":"Starace","year":"2021","journal-title":"Ther Adv Ophthalmol"},{"issue":"12","key":"10.1016\/j.xops.2026.101321_bib3","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1097\/IAE.0000000000000250","article-title":"Distribution of intraretinal exudates in diabetic macular edema during anti-vascular endothelial growth factor therapy observed by spectral domain optical coherence tomography and fundus photography","volume":"34","author":"Pemp","year":"2014","journal-title":"Retina"},{"issue":"5 Suppl","key":"10.1016\/j.xops.2026.101321_bib4","first-page":"786","article-title":"Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.xops.2026.101321_bib5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archopht.1996.01100140281004","article-title":"Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) report 22","volume":"114","author":"Chew","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.xops.2026.101321_bib6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archopht.1997.01100160043006","article-title":"Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group","volume":"115","author":"Fong","year":"1997","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.xops.2026.101321_bib7","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ajo.2011.08.041","article-title":"Association between hyperreflective foci in the outer retina, status of photoreceptor layer, and visual acuity in diabetic macular edema","volume":"153","author":"Uji","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"Supplement_1","key":"10.1016\/j.xops.2026.101321_bib8","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.2337\/dc26-S012","article-title":"Retinopathy, neuropathy, and foot care: standards of care in Diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.xops.2026.101321_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00417-025-07015-0","article-title":"Hard exudates in diabetic macular edema after intravitreal anti-VEGF therapy: a post-hoc analysis of the DRCR protocol T trial","volume":"264","author":"Pak","year":"2026","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2026.101321_bib10","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41433-026-04408-1","article-title":"Long term evolutions of hard exudates after anti-VEGF therapy for diabetic macular oedema","volume":"40","author":"Pak","year":"2026","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.xops.2026.101321_bib11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ophtha.2023.12.026","article-title":"Faricimab treat-and-extend for diabetic macular edema: Two-Year results from the randomized phase 3 YOSEMITE and RHINE trials","volume":"131","author":"Wong","year":"2024","journal-title":"Ophthalmology"},{"issue":"10326","key":"10.1016\/j.xops.2026.101321_bib12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","article-title":"Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials","volume":"399","author":"Wykoff","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.xops.2026.101321_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ophtha.2026.01.001","article-title":"Four-Year outcomes of Faricimab in diabetic macular edema: results from the RHONE-X extension trial","volume":"133","author":"Sheth","year":"2026","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.xops.2026.101321_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100798","article-title":"Effect of Faricimab versus aflibercept on hyperreflective foci in patients with diabetic macular edema from the YOSEMITE\/RHINE trials","volume":"5","author":"Chakravarthy","year":"2025","journal-title":"Ophthalmol Sci"},{"issue":"5","key":"10.1016\/j.xops.2026.101321_bib15","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.ophtha.2008.12.039","article-title":"Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema","volume":"116","author":"Bolz","year":"2009","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.xops.2026.101321_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A Guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"issue":"1","key":"10.1016\/j.xops.2026.101321_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0002-9394(82)90197-0","article-title":"New visual acuity charts for clinical research","volume":"94","author":"Ferris","year":"1982","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.xops.2026.101321_bib19","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1097\/IAE.0000000000000207","article-title":"The pearl necklace sign: a novel spectral domain optical coherence tomography finding in exudative macular disease","volume":"34","author":"Gelman","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101321_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ajo.2019.11.014","article-title":"Effect of intravitreal ranibizumab on intraretinal hard exudates in eyes with diabetic macular edema","volume":"211","author":"Srinivas","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.xops.2026.101321_bib21","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archophthalmol.2012.1107","article-title":"Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab","volume":"130","author":"Bressler","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.xops.2026.101321_bib22","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s40123-026-01338-9","article-title":"Real-World 6-Month treatment outcomes of faricimab in Turkey: the FARTURK Study","volume":"15","author":"Cakir","year":"2026","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"10.1016\/j.xops.2026.101321_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100975","article-title":"What lies beneath diabetic macular edema: latent phenotypic clustering and differential treatment responses to intravitreal therapies","volume":"6","author":"Cicinelli","year":"2026","journal-title":"Ophthalmol Sci"},{"issue":"12","key":"10.1016\/j.xops.2026.101321_bib24","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1016\/j.ophtha.2013.06.014","article-title":"Association between perifoveal hyperfluorescence and serous retinal detachment in diabetic macular edema","volume":"120","author":"Murakami","year":"2013","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.xops.2026.101321_bib25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ophtha.2014.10.028","article-title":"Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials","volume":"122","author":"Domalpally","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101321_bib26","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1038\/ncomms6962","article-title":"Endothelial destabilization by angiopoietin-2 via integrin beta1 activation","volume":"6","author":"Hakanpaa","year":"2015","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.xops.2026.101321_bib27","first-page":"6228","article-title":"Greater reduction in hard exudates with faricimab vs aflibercept in patients with DME: biomarker results from the phase 3 YOSEMITE\/RHINE trials","volume":"65","author":"Goldberg","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.xops.2026.101321_bib28","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1167\/iovs.13-11849","article-title":"Quantitative measurement of hard exudates in patients with diabetes and their associations with serum lipid levels","volume":"54","author":"Sasaki","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.xops.2026.101321_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/IAE.0000000000001545","article-title":"Quantification of intraretinal hard exudates in eyes with diabetic retinopathy by optical coherence tomography","volume":"38","author":"Srinivas","year":"2018","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.xops.2026.101321_bib30","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00592-021-01697-8","article-title":"Quantitative evaluation of hard exudates in diabetic macular edema by multicolor imaging and their associations with serum lipid levels","volume":"58","author":"Gong","year":"2021","journal-title":"Acta Diabetol"},{"issue":"6","key":"10.1016\/j.xops.2026.101321_bib31","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/IAE.0000000000003434","article-title":"Automatic detection and grading of diabetic macular edema based on a deep neural network","volume":"42","author":"Guo","year":"2022","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.xops.2026.101321_bib32","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s40123-024-00929-8","article-title":"Rate and predictors of misclassification of active diabetic macular edema as detected by an automated retinal image analysis System","volume":"13","author":"La Franca","year":"2024","journal-title":"Ophthalmol Ther"},{"issue":"8","key":"10.1016\/j.xops.2026.101321_bib33","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0161-6420(91)32145-6","article-title":"The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate","volume":"98","author":"Klein","year":"1991","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526002599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526002599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:21:52Z","timestamp":1789464112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914526002599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666914526002599"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2026.101321","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hard Exudates in Diabetic Macular Edema: Automated OCT Quantification and Longitudinal Response to Faricimab","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2026.101321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101321"}}